Methylenedioxypyrovalerone
| Clinical data | |
|---|---|
| Other names | MDPV; Monkey dust; 3′,4′-Methylenedioxy-α-(pyrrolidin-1-yl)valerophenone; MDPK; MD-αP-VP |
| Routes of administration | Oral, insufflation, intravenous, rectal, vaporization |
| Drug class | Stimulant; Norepinephrine–dopamine reuptake inhibitor |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Primarily urine (renal) |
| Identifiers | |
IUPAC name
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H21NO3 |
| Molar mass | 275.348 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
SMILES
| |
InChI
| |
| (verify) | |
Methylenedioxypyrovalerone (abbreviated MDPV, and also called monkey dust) is a stimulant of the cathinone class that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI).